InControl (US) expands atrial defibrillator trials:
This article was originally published in Clinica
InControl (US) is about to expand its European defibrillator trials to sites in France, Belgium and the Netherlands. Up to 12 centres may join the trial of Metrix, InControl's implantable atrial defibrillator which has been under investigation in London since October (see Clinica No 680, p 25). The company says it plans to apply for permission to conduct trials in additional European countries in the next few weeks.